by Bernardo Garcia Finanzas Personales | 04/03/2025 03:00 AM | TSLA
📉 Tesla's China sales fell nearly 50% year-over-year in February.
⚠️ Intense competition in the Chinese market is impacting Tesla's market share.
🚗 Deliveries are down for the fifth consecutive month despite government subsidies.
🆚 BYD is significantly outperforming Tesla in sales growth.
Read more!
by Bernardo Garcia Finanzas Personales | 04/03/2025 03:00 AM | ETL
🚀 Eutelsat shares surged following the EU's commitment to increase defense spending.
🇪🇺 The EU's increased defense spending is seen as a response to reduced US aid to Ukraine.
🛰️ Eutelsat is positioned as a competitor to Starlink in satellite services.
Read more!
by Bernardo Garcia Finanzas Personales | 04/03/2025 03:00 AM | TGT
📉 Target forecasts little to no sales growth this year, signaling ongoing struggles.
⚠️ The retailer is facing pressure on earnings due to weak sales and tariff uncertainties.
📉 Competitors like Walmart and Costco are outperforming Target due to their strength in groceries.
Read more!
by Bernardo Garcia Finanzas Personales | 04/03/2025 03:00 AM | GOOG
🤔 Google is being compared to a small-cap stock with potentially higher returns.
📈 Analyst believes Google could revalorize by 35% in the next two years.
⚠️ Google is considered lower risk compared to small-cap stocks, but faces risks related to its search dominance.
Read more!
by Bernardo Garcia Finanzas Personales | 03/03/2025 03:00 AM | ABBV
🚀 AbbVie is entering the competitive weight loss market by acquiring a next-generation obesity drug from Gubra.
💰 The deal involves a significant upfront payment and potential milestone payments.
💪 AbbVie aims to compete with Eli Lilly and Novo Nordisk in a market expected to reach $130 billion in annual sales by 2030.
❓ The analyst questions whether the high initial price is justified, given the crowded market.
Read more!